Table 2.
Summary for the assessments results in all groups.
| Group | MTT assay (% of cell viability mean ± SD |
Trypan blue (number of living cells) (14 days) count of viable cells x 105 ± SD | ALP activity Mean ± SD |
ARS staining (14 days) |
NF-KB assessment cyclic threshold (14 days) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 days | 7 days | 14 days | 3 days | 7 days | 14 days | % of stained + ve cells | (H-score) | 1st reading | 2nd- read-ing | 3rd reading | Mean ± SD | ||
| C-DPSCs | 0.82 ± 0.01 | 0.99 ± 0.10 | 1.35 ± 0.15 | 1.28 ± 0.03 | – | – | – | – | – | – | – | – | – |
| Percentage | 100.16 % | 100.27 % | 100.25 % | ||||||||||
| C-PDLSCs | 0.60 ± 0.03 | 1.04 ± 0.07 | 1.28 ± 0.11 | 2.42 ± 0.54 | – | – | – | – | – | – | – | – | – |
| Percentage | 99.89 % | 99.71 % | 100.16 % | ||||||||||
| L-DPSCs | 1.03 ± 0.04 | 1.43 ± 0.02 | 2.69 ± 0.08 | 8.82 ± 0.32 | – | – | – | – | – | – | – | – | – |
| Percentage | 128.44 % | 143.97 % | 199.04 % | ||||||||||
| L-PDLSCs | 0.77 ± 0.06 | 1.37 ± 0.04 | 2.14 ± 0.03 | 5.47 ± 0.58 | – | – | – | – | – | – | – | – | – |
| Percentage | 125.53 % | 131.38 % | 167.40 % | ||||||||||
| OM-DPSCs | – | – | – | – | 66.82 ± 4.82 | 135.79 ± 4.20 | 126.82 ± 3.11 | 10 | 10 | 33.52 | 32.29 | 32.72 | 32.84 ± 0.62 |
| OM-PDLSCs | – | – | – | – | 68.26 ± 2.69 | 109.76 ± 6.43 | 142.23 ± 5.96 | 5 | 5 | 32.72 | 31.52 | 32.65 | 32.30 ± 0.67 |
| L.OM-DPSCs | – | – | – | – | 87.86 ± 2.58 | 192.51 ± 6.94 | 200.19 ± 6.99 | 90 | 180 | 37.52 | 36.58 | 37.06 | 34.81 ± 0.41 |
| L.OM-PDLSCs | – | – | – | – | 73.77 ± 4.69 | 193.57 ± 2.60 | 193.57 ± 2.60 | 82 | 164 | 34.81 | 34.81 | 35.07 | 34.70 ± 0.44 |